REgulatory T Cell Therapy to Achieve Immunosuppression REduction — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(7 sites)
United States
Mayo Clinic in Arizona, Phoenix, Arizona Northwestern Memorial Hospital, Chicago, Illinois Mayo Clinic in Minnesota, Rochester, Minnesota Taiwan
Taichung Veterans General Hospital, Taichung National Cheng Kung University Hospital, Tainan National Taiwan University Hospital, Taipei Chang Gung Medical Foundation Hospital, Taoyuan District Last updated February 2026